Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016 (2016), Article ID 9570171, 7 pages
http://dx.doi.org/10.1155/2016/9570171
Clinical Study

Therapeutic Outcome of Second Primary Malignancies in Patients with Well-Differentiated Thyroid Cancer

1Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, No. 5, Fu-Shin Street, Guishan District, Taoyuan 333, Taiwan
2Department of Radiation Oncology, Chang Gung Memorial Hospital, Chang Gung University, No. 5, Fu-Shin Street, Guishan District, Taoyuan 333, Taiwan
3Department of Pathology, Chang Gung Memorial Hospital, Chang Gung University, No. 5, Fu-Shin Street, Guishan District, Taoyuan 333, Taiwan
4Department of General Surgery, Chang Gung Memorial Hospital, Chang Gung University, No. 5, Fu-Shin Street, Guishan District, Taoyuan 333, Taiwan

Received 9 November 2015; Revised 22 February 2016; Accepted 16 March 2016

Academic Editor: Thomas J. Fahey

Copyright © 2016 Miaw-Jene Liou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. K. Jung, M. P. Little, J. H. Lubin et al., “The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations,” Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 2, pp. E276–E285, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Davies and H. G. Welch, “Increasing incidence of thyroid cancer in the United States, 1973–2002,” Journal of the American Medical Association, vol. 295, no. 18, pp. 2164–2167, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Albores-Saavedra, D. E. Henson, E. Glazer, and A. M. Schwartz, “Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype—papillary, follicular, and anaplastic: a morphological and epidemiological study,” Endocrine Pathology, vol. 18, no. 1, pp. 1–7, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. I. D. Hay and G. G. Klee, “Thyroid cancer diagnosis and management,” Clinics in Laboratory Medicine, vol. 13, no. 3, pp. 725–734, 1993. View at Google Scholar · View at Scopus
  5. D. S. Cooper, G. M. Doherty, B. R. Haugen et al., “Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer,” Thyroid, vol. 19, no. 11, pp. 1167–1214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Pacini, M. Schlumberger, H. Dralle et al., “European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium,” European Journal of Endocrinology, vol. 154, no. 6, pp. 787–803, 2006. View at Google Scholar · View at Scopus
  7. Y. Y. Cho, J. Lim, C.-M. Oh et al., “Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea,” Cancer, vol. 121, no. 2, pp. 259–268, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. K.-Y. Ko, C.-H. Kao, C.-L. Lin, W.-S. Huang, and R.-F. Yen, “131I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: a nationwide population-based cohort study,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 42, no. 8, pp. 1172–1178, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. R. A. Delellis, R. V. Lloyd, P. U. Heitx et al., Pathology and Genetics of Tumours of Endocrine Organs, World Health Organization of Tumours, IARC, Lyon, France, 2004.
  10. S. E. Edge, D. R. Byrd, M. A. Carducci et al., AJCC Cancer Staging Manual, Springer, New York, NY, USA, 7th edition, 2009.
  11. D. D. Zhang, X.-H. Zhou, D. H. Freeman Jr., and J. L. Freeman, “A non-parametric method for the comparison of partial areas under ROC curves and its application to large health care data sets,” Statistics in Medicine, vol. 21, no. 5, pp. 701–715, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Howlader, A. M. Noone, M. Krapcho et al., Eds., SEER Cancer Statistics Review, 1975–2010, National Cancer Institute, Bethesda, Md, USA, 2013, http://seer.cancer.gov/csr/1975_2010/.
  13. C. Zafon, G. Obiols, and J. Mesa, “Second primary cancer in patients with papillary thyroid carcinoma,” Anticancer Research, vol. 33, no. 1, pp. 337–340, 2013. View at Google Scholar · View at Scopus
  14. S. E. Murray, D. F. Schneider, P. S. Bauer, R. S. Sippel, and H. Chen, “Synchronous and antecedent nonthyroidal malignancies in patients with papillary thyroid carcinoma,” The Journal of the American College of Surgeons, vol. 216, no. 6, pp. 1174–1180, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Liu, J. Shi, F. Mao, J. Wei, D. Fu, and J. Zhang, “Synchronous primary cancers of the thyroid and breast: a case report and review of the literature,” Oncology Letters, vol. 9, no. 1, pp. 351–354, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. K. C. Oeffinger, S. S. Baxi, D. Novetsky Friedman, and C. S. Moskowitz, “Solid Tumor second primary neoplasms: who is at risk, what can we do?” Seminars in Oncology, vol. 40, no. 6, pp. 676–689, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. H. C. Kim, D. Y. Yoon, Y. L. Seo et al., “Incidental thyroid lesions identified by ultrasound in patients with non-thyroidal head and neck cancer,” Acta Radiologica, vol. 54, no. 10, pp. 1153–1158, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. M. R. Gilbert and S. Kim, “Incidental thyroid cancer found during surgery for head and neck squamous cell carcinoma,” Otolaryngology-Head and Neck Surgery, vol. 147, no. 4, pp. 647–653, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Rubino, F. de Vathaire, M. E. Dottorini et al., “Second primary malignancies in thyroid cancer patients,” British Journal of Cancer, vol. 89, no. 9, pp. 1638–1644, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. N. G. Iyer, L. G. T. Morris, R. M. Tuttle, A. R. Shaha, and I. Ganly, “Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy,” Cancer, vol. 117, no. 19, pp. 4439–4446, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Blumhardt, E. A. Wolin, W. T. Phillips et al., “Current controversies in the initial post-surgical radioactive iodine therapy for thyroid cancer: a narrative review,” Endocrine-Related Cancer, vol. 21, no. 6, pp. R473–R484, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Grantzau and J. Overgaard, “Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients,” Radiotherapy and Oncology, vol. 114, no. 1, pp. 56–65, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Y. Ahn, H. S. Min, Y. Yeo et al., “Radioactive iodine therapy did not significantly increase the incidence and recurrence of subsequent breast cancer,” Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 9, pp. 3486–3493, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. Health Promotion Administration of Ministry of Health and Welfare, Cancer Registry Annual Report 2012, Health Promotion Administration of Ministry of Health and Welfare, Taipei, Taiwan, 2012.